China is moving at a dazzling speed, and U.S. FDA wants to be on board.
As FDA's presence in China enters its seventh year, the agency's warning letters to the country has soared five-fold.
FDA Tip-Toes In China To Push Data Integrity, Harmonization
US FDA warning letters to Chinese firms may be on the increase, but ties with the Chinese regulator appear to be growing. US FDA showcases how to get more done in fast-changing China via aligning with China FDA's aspiration for quality and international harmonization.
